PFKFB3对急性心肌梗死中多形核髓源性抑制细胞炎症活化的影响
该研究含临床观察与小鼠实验两部分。临床部分纳入镇江市第四人民医院急性冠脉综合征患者,AMI组25例循环PMN-MDSC比例(8.53±0.96)%高于非AMI组20例的(1.13±0.39)%(P<0.01),单核细胞PFKFB3表达亦升高(2-ΔΔCt:1.18±0.19 vs. 0.96±0.16,P<0.01),两者正相关(r=0.608,P=0.001)。小鼠实验显示AMI模型循环及心肌PMN-MDSC浸润增加,腹腔注射PKF-15(20 μg/g)可降低外周血(26.33±5.27)% vs.(75.12±5.02)%与心肌(20.87±2.97)% vs.(35.28±4.36)%的PMN-MDSC比例(均P<0.01),并降低PFKFB3及TNF-α、IL-1β、IL-6表达(均P<0.01),减轻心肌炎症损伤。
要点
- AMI患者(n=25)循环PMN-MDSC比例为(8.53±0.96)%,高于非AMI患者(n=20)的(1.13±0.39)%(P<0.01)。
- AMI患者外周血单核细胞PFKFB3基因表达为2-ΔΔCt 1.18±0.19,高于非AMI组的0.96±0.16(P<0.01),且与循环PMN-MDSC比例正相关(r=0.608,P=0.001)。
- 小鼠AMI模型外周血PMN-MDSC比例为(75.12±5.02)%,PKF-15干预组为(26.33±5.27)%;心肌组织分别为(35.28±4.36)% vs.(20.87±2.97)%,均P<0.01。
- PKF-15(20 μg/g腹腔注射)降低AMI小鼠心肌TNF-α mRNA(14.55±3.99 vs. 29.66±3.90)、IL-1β mRNA(8.72±1.35 vs. 18.53±2.43)、IL-6 mRNA(11.87±2.97 vs. 19.82±4.32),均P<0.01。
适用人群与场景
- 临床部分:镇江市第四人民医院收治的急性冠脉综合征患者,按临床诊断分为AMI组(n=25)与非AMI组(n=20)。
- 基础实验:6-8周龄雄性C57小鼠30只,随机分为正常对照组(n=5)、假手术组(n=5)、AMI模型组(n=10)和PFKFB3抑制剂PKF-15干预组(n=10)。
处置流程与药物剂量
- 小鼠AMI模型通过结扎左前降支冠状动脉(LADCA)复制,假手术组开胸后不结扎动脉。
- PKF-15干预组在LADCA结扎同时腹腔注射PKF-15(20 μg/g);正常对照组不作任何处理。
- 造模后24小时采集小鼠外周静脉血和心肌组织,检测循环PMN-MDSC比例及心肌组织PMN-MDSC浸润。
研究设计与关键结果
- 临床观察研究:AMI组循环PMN-MDSC比例为(8.53±0.96)%,非AMI组为(1.13±0.39)%,P<0.01;AMI组外周血单核细胞PFKFB3基因表达为2-ΔΔCt 1.18±0.19,非AMI组为0.96±0.16,P<0.01。
- Pearson相关分析显示AMI患者循环PMN-MDSC比例与单核细胞PFKFB3基因表达正相关(r=0.608,P=0.001)。
- 小鼠实验:AMI模型组循环PMN-MDSC比例及心肌组织PMN-MDSC浸润显著高于正常对照组和假手术组;PKF-15干预降低外周血PMN-MDSC比例[(26.33±5.27)% vs.(75.12±5.02)%]和心肌组织PMN-MDSC比例[(20.87±2.97)% vs.(35.28±4.36)%],均P<0.01。
- 光镜下AMI模型组心肌细胞排列紊乱、大量炎症细胞浸润;PKF-15干预可维持心肌细胞排列正常并减少炎症细胞浸润。
- AMI小鼠外周血和心肌组织PFKFB3基因表达及心肌组织炎症因子表达显著高于正常对照组和假手术组;PKF-15干预降低外周血PFKFB3 mRNA(2-ΔΔCt:1.01±0.09 vs. 1.40±0.12)和心肌组织PFKFB3 mRNA(0.95±0.09 vs. 1.47±0.10),以及心肌组织TNF-α mRNA(14.55±3.99 vs. 29.66±3.90)、IL-1β mRNA(8.72±1.35 vs. 18.53±2.43)、IL-6 mRNA(11.87±2.97 vs. 19.82±4.32),均P<0.01。
证据类型、等级与局限
- 证据类型:临床观察性研究联合小鼠基础实验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为PFKFB3活化与AMI期间PMN-MDSC炎症活化密切相关,抑制PFKFB3活性可抑制PMN-MDSC炎症活化并减轻心肌炎症损伤。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the correlation between 6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 3 (PFKFB3) and the inflammatory activation of polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC) in acute myocardial infarction (AMI), and to evaluate the effect of intervention targeting PFKFB3 on the inflammatory activation of PMN-MDSC during AMI.
METHODS: (1) Clinical trial section: a observational study was conducted. The patients with acute coronary syndrome (ACS) admitted to Zhenjiang Fourth People's Hospital were enrolled, and they were divided into AMI group and non-AMI group according to clinical diagnosis. The peripheral venous blood of the two groups was collected to detect the proportion of PMN-MDSC, and the expression of PFKFB3 gene in mononuclear cells was detected by real-time quantitative polymerase chain reaction (RT-qPCR). (2) Basic experiment section: a total of 30 male C57 mice (aged 6-8 weeks) were divided into normal control group (n = 5), Sham group (n = 5), AMI model group (n = 10) and PFKFB3 inhibitor PKF-15 intervention group (n = 10) according to random number table method. The AMI model of mice was reproduced by left anterior descending coronary artery (LADCA) ligation, and the mice in the Sham group did not attach the artery after thoracotomy. The PKF-15 intervention group was intraperitoneally injected with PKF-15 (20 μg/g) at the same time of LADCA ligation. Normal control mice did not receive any treatment. Peripheral venous blood and myocardial tissue of mice were collected 24 hours after modeling. Both the circulating PMN-MDSC ratio and the infiltration of PMN-MDSC in myocardial tissue were detected. After staining with hematoxylin-eosin (HE), the degree of inflammatory damage in mouse myocardial tissue was observed under light microscopy. PMN-MDSC were isolated from mice with flow cytometry, and the gene expressions of PFKFB3 and inflammatory factors were measured by RT-qPCR.
RESULTS: (1) Clinical trial section: the circulating PMN-MDSC ratio of patients in the AMI group (n = 25) was significantly higher than that in the non-AMI group [n = 20; (8.53±0.96)% vs. (1.13±0.39)%, P < 0.01], and PFKFB3 gene expression in the peripheral blood mononuclear cells was also increased (2-ΔΔCt: 1.18±0.19 vs. 0.96±0.16, P < 0.01). Pearson correlation analysis showed that circulating PMN-MDSC ratio was positively correlated with PFKFB3 gene expression in mononuclear cells in AMI patients (r = 0.608, P = 0.001). (2) Basic experimental section: the circulating PMN-MDSC ratio and the infiltration of PMN-MDSC in myocardial tissue of AMI mice were significantly higher than those in the normal control group and Sham group. PFK-15 intervention could reduce the ratio of PMN-MDSC in the peripheral blood and myocardial tissue of AMI mice [(26.33±5.27)% vs. (75.12±5.02)% in peripheral blood, (20.87±2.97)% vs. (35.28±4.36)% in myocardial tissue, both P < 0.01]. Under light microscopy, the myocardial cells in the AMI modal group were disordered and a large number of inflammatory cells infiltrated. PFK-15 intervention could maintain a normal arrangement of cardiomyocytes and reduce the infiltration of inflammatory cells. The gene expression levels of PFKFB3 in the peripheral blood and myocardial tissue as well as the inflammatory factors in the myocardial tissue of AMI mice were significantly higher than those in the normal control group and Sham group. PKF-15 intervention could effectively reduce the gene expression levels of PFKFB3 in the peripheral blood and myocardial tissue as well as the inflammatory factors in the myocardial tissue of AMI mice [PFKFB3 mRNA (2-ΔΔCt): 1.01±0.09 vs. 1.40±0.12 in peripheral blood, 0.95±0.09 vs. 1.47±0.10 in myocardial tissue; myocardial tissue tumor necrosis factor-α (TNF-α) mRNA (2-ΔΔCt) was 14.55±3.99 vs. 29.66±3.90, interleukin-1β (IL-1β) mRNA (2-ΔΔCt) was 8.72±1.35 vs. 18.53±2.43, IL-6 mRNA (2-ΔΔCt) was 11.87±2.97 vs. 19.82±4.32, all P < 0.01].
CONCLUSIONS: The activation of PFKFB3 is closely related to the inflammatory activation of PMN-MDSC during AMI. Inhibition of PFKFB3 activity can inhibit the inflammatory activation of PMN-MDSC and reduce myocardial inflammatory injury.
参考来源
- Yu Z, Wu Y, Liu D, et al. [Effect of PFKFB3 on inflammatory activation of polymorphonuclear myeloid-derived suppressor cell in acute myocardial infarction]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024. PMID: 38404271. doi:10.3760/cma.j.cn121430-20230703-00002
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。